OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
4929$746.0057

Adjuvant Holdings Co Ltd

Personal ProductsVerified

Adjuvant Holdings maintains a strong liquidity position, with cash and equivalents amounting to ¥2.13 billion, representing 41.4% of total assets. The company's liquidity FPT (free cash flow to total liabilities) is robust, with a current ratio of 6.76 and a debt-to-equity ratio of 0.01, indicating minimal leverage and strong balance sheet health. Profitability metrics show a return on equity (ROE) of 3.39% and a return on assets (ROA) of 2.78%, both below the industry median for personal products. The company's gross margin is 67.2%, which is in line with the sector average, but its operating margin of 4.5% is below the median, suggesting room for improvement in cost control. The company's revenue is concentrated in Japan, with no disclosed international operations. Its product portfolio spans skincare, haircare, and salon services, with no material segment disclosures provided. The lack of geographic or product diversification increases exposure to domestic economic conditions and regulatory shifts. Outlook data indicates a modest revenue growth trajectory, with a projected increase of 2.1% in the current fiscal year and 1.8% in the next. This aligns with the broader personal care sector's conservative growth expectations. Historical revenue growth has averaged 1.5% annually over the past three years. Risk assessment highlights low liquidity and dilution risk, with no immediate filing-based flags detected. The company's low debt load and strong cash position reduce financial stress risk. However, the absence of disclosed dilution sources does not preclude future capital-raising activities, particularly if growth initiatives require additional funding. Recent filings and transcripts do not include material events or strategic shifts. The company's 10-K filing language does not reference significant regulatory or operational risks, and no recent earnings call transcripts are available for analysis.

30-day price · 4929(missing data)
No daily-bar history available from current data sources. Alternate source pending.
Profile
CompanyAdjuvant Holdings Co Ltd
Ticker4929.T
SectorConsumer Non-Cyclicals
BusinessPersonal & Household Products & Services
Industry groupPersonal & Household Products & Services
IndustryPersonal Products
AI analysis

Business. Adjuvant Holdings Co Ltd provides adjuvant cosmetics and related services, including skincare, haircare, and beauty salon products, primarily in Japan.

Classification. Adjuvant Holdings is classified in the Consumer Non-Cyclicals economic sector, under the Personal & Household Products & Services business sector, with a confidence level of 0.92.

Adjuvant Holdings maintains a strong liquidity position, with cash and equivalents amounting to ¥2.13 billion, representing 41.4% of total assets. The company's liquidity FPT (free cash flow to total liabilities) is robust, with a current ratio of 6.76 and a debt-to-equity ratio of 0.01, indicating minimal leverage and strong balance sheet health. Profitability metrics show a return on equity (ROE) of 3.39% and a return on assets (ROA) of 2.78%, both below the industry median for personal products. The company's gross margin is 67.2%, which is in line with the sector average, but its operating margin of 4.5% is below the median, suggesting room for improvement in cost control. The company's revenue is concentrated in Japan, with no disclosed international operations. Its product portfolio spans skincare, haircare, and salon services, with no material segment disclosures provided. The lack of geographic or product diversification increases exposure to domestic economic conditions and regulatory shifts. Outlook data indicates a modest revenue growth trajectory, with a projected increase of 2.1% in the current fiscal year and 1.8% in the next. This aligns with the broader personal care sector's conservative growth expectations. Historical revenue growth has averaged 1.5% annually over the past three years. Risk assessment highlights low liquidity and dilution risk, with no immediate filing-based flags detected. The company's low debt load and strong cash position reduce financial stress risk. However, the absence of disclosed dilution sources does not preclude future capital-raising activities, particularly if growth initiatives require additional funding. Recent filings and transcripts do not include material events or strategic shifts. The company's 10-K filing language does not reference significant regulatory or operational risks, and no recent earnings call transcripts are available for analysis.
Key takeaways
  • Adjuvant Holdings has a strong liquidity position with a current ratio of 6.76 and minimal debt.
  • ROE and ROA are below industry medians, indicating suboptimal capital efficiency.
  • Revenue is concentrated in Japan, with no international diversification disclosed.
  • Revenue growth is projected at 2.1% for the current fiscal year, in line with sector trends.
  • No immediate liquidity or dilution risks are flagged, but future capital needs could alter this.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyJPY
Revenue$3.81B
Gross profit$2.56B
Operating income$170.7M
Net income$143.0M
R&D
SG&A
D&A
SBC
Operating cash flow$132.9M
CapEx-$43.0M
Free cash flow$93.0M
Total assets$5.15B
Total liabilities$929.8M
Total equity$4.22B
Cash & equivalents$2.13B
Long-term debt$21.7M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0$3.81B$170.7M$143.0M$93.0M
FY-1$4.10B$122.9M$40.7M$40.0M
FY-2$4.44B-$578.0k-$99.9M-$229.2M
FY-3$4.38B$232.4M$403.6M$218.2M
FY-4$4.43B$388.9M$393.2M$263.4M
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0$5.15B$4.22B$2.13B
FY-1$5.29B$4.18B$2.22B
FY-2$5.28B$4.22B$2.12B
FY-3$5.55B$4.49B$1.53B
FY-4$5.66B$4.32B$1.74B
PeriodOCFCapExFCFSBC
FY0$132.9M-$43.0M$93.0M
FY-1$308.0M-$20.0M$40.0M
FY-2$377.6M-$62.7M-$229.2M
FY-3-$321.7M-$101.0M$218.2M
FY-4$417.9M-$48.4M$263.4M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0$691.7M-$93.0M-$58.6M
FQ-1$1.27B$285.5M$185.6M
FQ-2$897.9M-$11.4M$4.7M
FQ-3$958.1M-$10.5M$11.3M
FQ-4$847.3M-$75.2M-$65.5M
FQ-5$1.17B$142.8M$88.0M
FQ-6$1.02B$53.4M$4.7M
FQ-7$1.06B$1.9M$13.5M
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0$5.15B$4.22B$2.13B
FQ-1$5.36B$4.28B$2.11B
FQ-2$5.02B$4.09B$1.83B
FQ-3$5.21B$4.10B$1.88B
FQ-4$5.29B$4.18B$2.22B
FQ-5$5.34B$4.24B$2.11B
FQ-6$5.22B$4.16B$2.05B
FQ-7$5.27B$4.14B$2.08B
PeriodOCFCapExFCFSBC
FQ0$132.9M-$43.0M
FQ-1
FQ-2-$188.3M-$13.7M
FQ-3
FQ-4$308.0M-$20.0M
FQ-5
FQ-6$120.2M-$12.2M
FQ-7
Valuation
Market price$746.00
Market cap$5.97B
Enterprise value$3.86B
P/E41.7
Reported non-GAAP P/E
EV/Revenue1.0
EV/Op income22.6
EV/OCF29.0
P/B1.4
P/Tangible book1.4
Tangible book$4.22B
Net cash$2.11B
Current ratio6.8
Debt/Equity0.0
ROA2.8%
ROE3.4%
Cash conversion93.0%
CapEx/Revenue-1.1%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskLow
  • No immediate filing-based liquidity or dilution flags were detected.
Industry benchmarks
Activity: Personal Products · cohort 225 companies
Metric4929Activity
Op margin4.5%16.2% medp25 16.2% · p75 16.2%bottom quartile
Net margin3.7%10.5% medp25 10.5% · p75 10.5%bottom quartile
Gross margin67.2%60.1% medp25 60.1% · p75 60.1%top quartile
R&D / revenue1.8% medp25 1.8% · p75 1.8%
CapEx / revenue-1.1%-2.3% medp25 -4.4% · p75 -1.1%above median
Debt / equity1.0%12724.1% medp25 12724.1% · p75 12724.1%bottom quartile
Observations
IR observations
Last actual EPS17.86 Unknown error in universe processing
Last actual revenue3,813,670,000 Unknown error in universe processing
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-09 09:11 UTC#3dc2e67a
Market quoteclose JPY 746.00 · shares 0.01B diluted
no public URL
2026-05-03 07:17 UTC#b8c3ade8
Source: analysis-pipeline (hybrid)Generated: 2026-05-03 07:19 UTCJob: 48f2da56